Tattoo marks could help surgeons save more breasts in cancer fight
NCT ID NCT07478900
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether tattooing the skin over a breast tumor before chemotherapy can help surgeons later remove the cancer completely while saving as much healthy breast tissue as possible. Thirty women with breast cancer will get their tumor edges marked with tattoo ink, then receive standard chemotherapy. After chemo, the tattoo marks guide the surgeon during breast-conserving surgery. The goal is to see if this method leads to clean surgical margins and avoids the need for a full mastectomy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- skin tattooing of tumor margins
- What this could lead to
- If successful, this tattooing method could help surgeons remove breast cancer more precisely, potentially allowing more women to keep their breasts instead of needing a mastectomy.
- What could go wrong
- This is a small, early study with only 30 participants, so results may not apply to everyone. Tattooing might cause allergic reactions or make it harder to see tumor changes during chemotherapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AIIMS Bhubaneswar
RECRUITINGBhubaneswar, Odisha, 751019, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your gut bacteria might hold the key to lung cancer treatment
- Triple-Action antibody takes aim at advanced breast cancer
- New radiation approach aims to boost lung cancer treatment in poor responders
- Tiny drug particles aim to shrink breast tumors
- Triple threat: radiation plus Immuno-Chemo shows promise for lung cancer
- New drug INV-6452 targets Hard-to-Treat breast cancers